Bank of New York Mellon
ACERW

Bank of New York Mellon’s Acer Therapeutics Inc Warrant ACERW Stock Holding History

Bank of New York Mellon’s Portfolio ACERW Stock Details ACERW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-305,425
Closed -$1K – 4420
2018
Q1 		$1K Sell
305,425
-40,153
-12% -$317 ﹤0.01% 4310
2017
Q4 		$4K Buy
345,578
+45,593
+15% +$1.51K ﹤0.01% 4349
2017
Q3 		$23K Buy
+299,985
New +$24.7K ﹤0.01% 4206

Bank of New York Mellon's ACERW Position: Q2 2018 in Review

Bank of New York Mellon sold out of Acer Therapeutics Inc Warrant (ACERW) in Q2 2018, closing a stake of 305,425 shares — an estimated $1K sold.

Bank of New York Mellon first reported a position in ACERW in Q3 2017 and held it in 3 quarters. The position peaked at $23K in Q3 2017. 0 funds tracked by Wall St. Rank hold ACERW as of Q2 2018.

  • Bank of New York Mellon reported no remaining Acer Therapeutics Inc Warrant position as of Q2 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 305,425 Acer Therapeutics Inc Warrant shares in Q2 2018, an estimated $1K.
  • Bank of New York Mellon first reported a position in Acer Therapeutics Inc Warrant in Q3 2017 and held it in 3 quarters.
  • Bank of New York Mellon's Acer Therapeutics Inc Warrant position peaked at $23K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Acer Therapeutics Inc Warrant as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.